These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29962813)

  • 61. Hepatitis C virus vaccines in the era of new direct-acting antivirals.
    Shi C; Ploss A
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):171-85. PubMed ID: 23363265
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting.
    Chirino-Sprung RA; Dehesa M; Wolpert E; Corona-Lau C; García-Juarez I; Sánchez-Ávila JF; Moctezuma-Velázquez C; Kershenobich D
    Rev Invest Clin; 2016; 68(4):203-12. PubMed ID: 27623039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.
    Leblebicioglu H; Arends JE; Ozaras R; Corti G; Santos L; Boesecke C; Ustianowski A; Duberg AS; Ruta S; Salkic NN; Husa P; Lazarevic I; Pineda JA; Pshenichnaya NY; Tsertswadze T; Matičič M; Puca E; Abuova G; Gervain J; Bayramli R; Ahmeti S; Koulentaki M; Kilani B; Vince A; Negro F; Sunbul M; Salmon D;
    Antiviral Res; 2018 Feb; 150():9-14. PubMed ID: 29217468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
    Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
    [No Abstract]   [Full Text] [Related]  

  • 68. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
    Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 70. New Antiviral Agents for Treatment of Hepatitis C.
    Egerman RS
    Clin Obstet Gynecol; 2019 Dec; 62(4):823-834. PubMed ID: 31094712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.
    Gentile I; Maraolo AE; Niola M; Graziano V; Borgia G; Paternoster M
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1227-1234. PubMed ID: 27607920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.
    Mauro E; Crespo G; Montironi C; Londoño MC; Hernández-Gea V; Ruiz P; Sastre L; Lombardo J; Mariño Z; Díaz A; Colmenero J; Rimola A; Garcia-Pagán JC; Brunet M; Forns X; Navasa M
    Hepatology; 2018 May; 67(5):1683-1694. PubMed ID: 28960366
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis C virus infection in children and adolescents.
    Indolfi G; Easterbrook P; Dusheiko G; El-Sayed MH; Jonas MM; Thorne C; Bulterys M; Siberry G; Walsh N; Chang MH; Meyers T; Giaquinto C; Wirth S; Chan PL; Penazzato M
    Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):477-487. PubMed ID: 30982721
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Cirrhosis of the liver and HCV].
    Hejda V
    Vnitr Lek; 2015 Nov; 61 Suppl 4():4s13-23. PubMed ID: 26667616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.
    Saludes V; González V; Planas R; Matas L; Ausina V; Martró E
    World J Gastroenterol; 2014 Apr; 20(13):3431-42. PubMed ID: 24707126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
    Rao HY; Duan ZP; Wang GQ; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Expert advices for evaluating clinical trials of direct-acting antiviral agents for hepatitis C].
    Research Group for New Drug's Clinical Evalutaion of Critical Diseases and Platform Construction of Integrated Technology
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):161-4. PubMed ID: 27095756
    [No Abstract]   [Full Text] [Related]  

  • 79. Hepatitis C Virus Infection in the Older Patient.
    Reid M; Price JC; Tien PC
    Infect Dis Clin North Am; 2017 Dec; 31(4):827-838. PubMed ID: 29079161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacology Update for the Treatment of Hepatitis C Virus.
    Hopkins L; Dunlap T; Cline H
    Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.